Your browser doesn't support javascript.
loading
SV-BR-1-GM, a Clinically Effective GM-CSF-Secreting Breast Cancer Cell Line, Expresses an Immune Signature and Directly Activates CD4+ T Lymphocytes.
Lacher, Markus D; Bauer, Gerhard; Fury, Brian; Graeve, Sanne; Fledderman, Emily L; Petrie, Tye D; Coleal-Bergum, Dane P; Hackett, Tia; Perotti, Nicholas H; Kong, Ying Y; Kwok, William W; Wagner, Joseph P; Wiseman, Charles L; Williams, William V.
Afiliação
  • Lacher MD; BriaCell Therapeutics Corp., Berkeley, CA, United States.
  • Bauer G; GMP Facility, Institute for Regenerative Cures, University of California, Davis (UCD), Sacramento, CA, United States.
  • Fury B; GMP Facility, Institute for Regenerative Cures, University of California, Davis (UCD), Sacramento, CA, United States.
  • Graeve S; BriaCell Therapeutics Corp., Berkeley, CA, United States.
  • Fledderman EL; GMP Facility, Institute for Regenerative Cures, University of California, Davis (UCD), Sacramento, CA, United States.
  • Petrie TD; GMP Facility, Institute for Regenerative Cures, University of California, Davis (UCD), Sacramento, CA, United States.
  • Coleal-Bergum DP; GMP Facility, Institute for Regenerative Cures, University of California, Davis (UCD), Sacramento, CA, United States.
  • Hackett T; GMP Facility, Institute for Regenerative Cures, University of California, Davis (UCD), Sacramento, CA, United States.
  • Perotti NH; GMP Facility, Institute for Regenerative Cures, University of California, Davis (UCD), Sacramento, CA, United States.
  • Kong YY; Benaroya Research Institute at Virginia Mason, Seattle, WA, United States.
  • Kwok WW; Benaroya Research Institute at Virginia Mason, Seattle, WA, United States.
  • Wagner JP; BriaCell Therapeutics Corp., Berkeley, CA, United States.
  • Wiseman CL; BriaCell Therapeutics Corp., Berkeley, CA, United States.
  • Williams WV; BriaCell Therapeutics Corp., Berkeley, CA, United States.
Front Immunol ; 9: 776, 2018.
Article em En | MEDLINE | ID: mdl-29867922

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Linfócitos T CD4-Positivos / Vacinas Anticâncer / Linhagem Celular Tumoral / Imunoterapia Tipo de estudo: Prognostic_studies Limite: Female / Humans Idioma: En Revista: Front Immunol Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Linfócitos T CD4-Positivos / Vacinas Anticâncer / Linhagem Celular Tumoral / Imunoterapia Tipo de estudo: Prognostic_studies Limite: Female / Humans Idioma: En Revista: Front Immunol Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Estados Unidos